For a short-term investment strategy, the company has poor fundamentals.
Strengths
Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 45% by 2023.
Historically, the company has been releasing figures that are above expectations.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Within the weekly time frame the stock shows a bullish technical configuration above the support level at 121.25 USD
Weaknesses
Stock prices approach a strong long-term resistance in weekly data at USD 181.18.
The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
The group shows a rather high level of debt in proportion to its EBITDA.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
With an enterprise value anticipated at 5.06 times the sales for the current fiscal year, the company turns out to be overvalued.
With an expected P/E ratio at 126.8 and 41.12 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company is not the most generous with respect to shareholders' compensation.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the past year, analysts have significantly revised downwards their profit estimates.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
